Skip to content

Clinical trials

Withdrawn Phase 2 Inflammation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Status: Withdrawn Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20101
20142
20161
20191
20201
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Withdrawn11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Inmune Bio, Inc.1
McMaster Children's Hospital1
National Heart, Lung, and Blood Institute (NHLBI)1
Novo Nordisk A/S1
Second Affiliated Hospital, Zhejiang University, School of Medicine1
Stanford University1
University Hospital, Akershus1
University of California, Irvine1
University of Florida1
University of Leicester1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation11
Atherosclerosis2
Alzheimer Disease1
Aortic Aneurysm, Abdominal1
Arthritis, Rheumatoid1
Brain Diseases1
Carotid Artery Diseases1
Carotid Stenosis1
Central Nervous System Diseases1
Cognitive Dysfunction1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.